Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 3,765 | 218 | 257 | 224 | 2,679 |
| Cost of Goods | 142 | 108 | 99 | 102 | 102 |
| Gross Profit | 3,623 | 110 | 158 | 122 | 2,577 |
| Operating Expenses | 2,036 | 2,287 | 3,336 | 3,362 | 3,389 |
| Operating Income | 1,729 | -2,069 | -3,079 | -3,138 | -710 |
| Interest Expense | 196 | 215 | 233 | 249 | 265 |
| Other Income | 1 | 34 | 24 | 3 | 59 |
| Pre-tax Income | 1,534 | -2,250 | -3,288 | -3,384 | -916 |
| Net Income Continuous | 1,534 | -2,250 | -3,288 | -3,384 | -916 |
| Net Income | $1,534 | $-2,250 | $-3,288 | $-3,384 | $-916 |
| EPS Basic Total Ops | 0.13 | -0.19 | -0.28 | -0.28 | -0.09 |
| EPS Basic Continuous Ops | 0.13 | -0.19 | -0.28 | -0.29 | -0.09 |
| EPS Diluted Total Ops | 0.13 | -0.19 | -0.28 | -0.28 | -0.09 |
| EPS Diluted Continuous Ops | 0.13 | -0.19 | -0.28 | -0.29 | -0.09 |
| EBITDA(a) | $1,847 | $-1,943 | $-2,947 | $-2,993 | $-562 |